Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment Refractory Soft Tissue Myoepithelial Carcinoma With an ARID1A Mutation.

Journal of pediatric hematology/oncology - 1 May 2023

Ashcroft Cody R, Penney Scott W, Whiteway Susan L

Abstract excerpt

Soft tissue myoepithelial carcinoma is a rare tumor first reported in the salivary gland. There is considerable tumor heterogeneity between pathology findings, tumor aggressiveness, and response to treatment. Recent molecular testing has identified recurrent genetic changes with PLAG mutations in salivary gland primary tumors and loss of SMARCB1 and EWSR1/FUS gene changes in myoepithelial carcinoma. SMARCB1 is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Carcinoma
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Nuclear Proteins

Share to SMARCB1 Protein

Share to Transcription Factors

Share to Young Adult

Source

Identifiers

PMID: 37083274
DOI: 10.1097/MPH.0000000000002650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment Refractory Soft Tissue Myoepithelial Carcinoma With an ARID1A Mutation.PMID 37083274Read ↗

Myoepithelial tumor of soft tissue: histology and genetics of an evolving entity.Semantic proximity Read ↗

Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future DevelopmentsSemantic proximity Read ↗

Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic StressSemantic proximity Read ↗

ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma ProgressionSemantic proximity Read ↗

Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial CarcinomaSemantic proximity Read ↗

Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy.Semantic proximity Read ↗

<i>EWSR1‐POU5F1</i> fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the <i>EWSR1</i> geneSemantic proximity Read ↗

SMARCB1 (INI1) Deficient Tumours of the Uterine Cervix: Report of Two Cases, Including One Associated With an NTRK FusionSemantic proximity Read ↗

ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell linesSemantic proximity Read ↗

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerSemantic proximity Read ↗

A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpartSemantic proximity Read ↗

Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion TranscriptsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.